Krzysztof Kamiński

24PUBLICATIONS
33CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsClinical pharmacology and therapeuticsGene expression (incl. microarray and other genome-wide approaches)Cellular nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 29, 2026
Second-Generation of Deuterium-Substituted Glutamate Uptake Enhancers Exhibit Superior Drug-Like Properties in Preclinical Evaluation.

|May 01, 2026
Novel 3-Methoxypropanamide Derivatives as Potential Antiseizure and Antinociceptive Agents: Experimental Evidence from In Vitro and In Vivo Studies.

|Oct 29, 2025
Novel Dual 5-HT7 Antagonists and Sodium Channel Inhibitors as Potential Therapeutic Agents with Antidepressant and Anxiolytic Activities.

Anna Czopek, Paulina Koczurkiewicz-Adamczyk, Katarzyna Wójcik-Pszczoła

|Feb 27, 2025
Effect of SSR504734, a Selective Glycine Transporter Type 1 Inhibitor, on Seizure Thresholds, Neurotransmitter Levels, and Inflammatory Markers in Mice.

Nikola Gapińska, Piotr Wlaź, Elżbieta Wyska

|Nov 27, 2024
Discovery of New 3-(Benzo[b]Thiophen-2-yl)Pyrrolidine-2,5-Dione Derivatives as Potent Antiseizure and Antinociceptive Agents-In Vitro and In Vivo Evaluation.

Anna Rapacz, Marcin Jakubiec, Michał Abram

|Nov 08, 2024
Enhancement of Glutamate Uptake as Novel Antiseizure Approach: Preclinical Proof of Concept.

Krzysztof Kamiński, Katarzyna Socała, Michał Abram

Pageof 4

Frequent Collaborators

12 joint publications

Michał Abram

9 joint publications

Katarzyna Socała

8 joint publications

Piotr Wlaź

6 joint publications

Anna Rapacz